Physostigmine should be used more readily for antimuscarinic toxicity: PRO.
Andrew H DawsonPublished in: British journal of clinical pharmacology (2021)
Physostigmine is the preferred treatment for antimuscarinic toxicity. Its use has a clear biological rationale and is supported by extensive clinical use which demonstrated effectiveness and safety.